CompletedNot Applicable

Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents

Germany400 participantsStarted 2014-11

Plain-language summary

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, a special intervention program (CHIMPs = Children of mentally ill parents) was developed. The study at hand will implement this intervention program at five sites in Germany and will further evaluate its effectiveness. The CHIMPs intervention is assumed to reduce children's psychopathology and enhance their health related quality of life.

Who can participate

Age range3 Years – 19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Family with at least one psychiatrically ill parent and at least one child between the age of 3 and 19 years * Consent to participate in the study * Sufficient knowledge of the German language of parents and children Exclusion Criteria: * Severe psychiatric disorders and impairments with acute symptoms such as suicidal tendencies, massive self-injurious behaviour, acute psychotic symptoms etc., making a stationary treatment inevitable and making a ambulatory intervention appear contraindicated (These patients are placed in stationary treatment) * Children with severe symptoms in the control group will be placed at a participating psychotherapist. Nevertheless, they stay in the control group (as TAU).

What they're measuring

children's psychiatric symptomatology (Kiddie-SADS interview)

Timeframe: at the beginning of the study (on study enrolment)

children's psychiatric symptomatology (Child behaviour checklist)

Timeframe: at the beginning of the study (on study enrolment)

children's psychiatric symptomatology (assessed by Youth Self Report)

Timeframe: at the beginning of the study (on study enrolment)

children's psychiatric symptomatology (assessed by the SGKJ)

Timeframe: at the beginning of the study (on study enrolment)

children's psychiatric symptomatology (Kiddie-SADS interview)

Timeframe: after the treatment (after 6 months)

children's psychiatric symptomatology (Kiddie-SADS interview)

Timeframe: after the follow-up period (after 18 months)

children's psychiatric symptomatology (Child behaviour checklist)

Timeframe: after the treatment (after 6 months)

Trial details

NCT IDNCT02308462

SponsorSilke Wiegand-Grefe, Prof. Dr.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06

View on ClinicalTrials.gov More Schizophrenia and Disorders With Psychotic Features trials